Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adipose-derived mesenchymal stem cells combined with platelet-rich plasma for chronic discogenic low back pain
RBR-5d9p457Phase 1Not yet recruiting
- Sponsor
- Ebserh
- Start
- Dec 2026
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
Phase 1, randomised, single-blind trial of autologous adipose-derived mesenchymal stromal cells in degenerative disc disease (DDD) (2 arms), sponsored by Ebserh. Planned start Dec 2026; status: not yet recruiting.
02
Drugs
autologous adipose-derived mesenchymal stromal cells
03
Conditions
degenerative disc disease (DDD)
Beyond the preview
Go deeper on RBR-5d9p457.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-5d9p457.